- Title
- State Board of Pharmacy - Prohibition on Discrimination Against 340B Drug Distribution
- Sponsored by
- Delegates Guzzone, Bagnall, Hill, Kaiser, R. Lewis, White Holland, Woods, Alston, Bhandari, Chisholm, Cullison, Hutchinson, S. Johnson, Kerr, Kipke, Lopez, Martinez, M. Morgan, Pena-Melnyk, Reilly, Rosenberg, Szeliga, and Taveras
- Status
- Approved by the Governor - Chapter 962
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Prohibiting a 340B manufacturer from taking certain direct or indirect actions to limit or restrict the acquisition or delivery of a 340B drug; making a violation of the Act an unfair, abusive, or deceptive trade practice within the meaning of the Consumer Protection Act; and requiring the Maryland Prescription Drug Affordability Board to conduct a study of the 340B Program and report its findings and recommendations to certain committees of the General Assembly by July 1, 2026.
Committees
- Opposite:
- Finance
Committee Testimony
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
12-101,
12-6C-09.1 )
Last Updated: 5/23/2024 5:21 PM